Free Trial

Innate Pharma (IPHA) Institutional Ownership

Innate Pharma logo
$1.37 -0.14 (-9.27%)
Closing price 05/7/2026 04:00 PM Eastern
Extended Trading
$1.38 +0.01 (+1.09%)
As of 05/7/2026 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Innate Pharma (NASDAQ:IPHA)

Current
Institutional Ownership
Percentage
0.16%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$247.61K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$12.69K
Get IPHA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Innate Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

IPHA Institutional Buying and Selling by Quarter

Innate Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026OLD Mission Capital LLC28,431$50K0.0%N/A0.030%
2/18/2026Millennium Management LLC20,308$36K0.0%N/A0.022%
2/12/2026Jane Street Group LLC92,753$162K0.0%N/A0.099%
11/17/2025Citadel Advisors LLC20,042$39K0.0%-24.7%0.022%
4/17/2025Exchange Traded Concepts LLC62,752$112K0.0%-18.9%0.075%
10/10/2024Exchange Traded Concepts LLC77,350$177K0.0%-10.3%0.096%
2/13/2024Optiver Holding B.V.22,705$64K0.0%-88.1%0.028%
1/5/2024Exchange Traded Concepts LLC46,888$131K0.0%+34.0%0.058%
11/13/2023Optiver Holding B.V.190,219$481K0.0%+132.6%0.236%
10/18/2023Exchange Traded Concepts LLC34,998$89K0.0%-17.5%0.043%
8/10/2023Optiver Holding B.V.81,796$257K0.0%-63.5%0.102%
7/20/2023Exchange Traded Concepts LLC42,431$133K0.0%N/A0.053%
5/11/2023Optiver Holding B.V.224,097$636K0.0%+112.3%0.279%
2/14/2023Susquehanna International Group LLP13,315$50K0.0%N/A0.017%
2/10/2023Optiver Holding B.V.105,534$394K0.0%-43.1%0.132%
8/10/2022Optiver Holding B.V.181,944$491K0.0%+366.8%0.228%
2/9/2022Alps Advisors Inc.93,718$429K0.0%N/A0.118%


IPHA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IPHA shares?

During the previous two years, the following institutional investors and hedge funds held shares of Innate Pharma shares: Jane Street Group LLC ($162K), Exchange Traded Concepts LLC ($112K), OLD Mission Capital LLC ($50K), and Citadel Advisors LLC ($39K), Millennium Management LLC ($36K).Learn more on Innate Pharma's institutional investors.

What percentage of Innate Pharma's stock is owned by institutional investors?

0.16% of Innate Pharma's stock is owned by institutional investors. Learn more on IPHA's institutional investor holdings.

Which institutional investors have been buying Innate Pharma's stock?

The following institutional investors have purchased Innate Pharma's stock in the last 24 months: Jane Street Group LLC ($92.75K), OLD Mission Capital LLC ($28.43K), and Millennium Management LLC ($20.31K).

How much institutional buying is happening at Innate Pharma?

Institutional investors have bought a total of 141,492 shares in the last 24 months. This purchase volume represents approximately $247.61K in transactions.

Which of Innate Pharma's major shareholders have been selling company stock?

The following institutional investors have sold Innate Pharma stock in the last 24 months: Citadel Advisors LLC ($6.58K).

How much institutional selling is happening at Innate Pharma?

Institutional investors have sold a total of 6,575 shares in the last 24 months. This volume of shares sold represents approximately $12.69K in transactions.



This page (NASDAQ:IPHA) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners